Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1975
Source ID: NCT01182727
Associated Drug: Salsalate
Title: Salsalate for Insulin Resistance in Schizophrenia
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01182727/results
Conditions: Schizophrenia|Insulin Resistance
Interventions: DRUG: salsalate
Outcome Measures: Primary: Side Effects of Salsalate, This Measure is reporting the number of participants with side effects as reported on the Side Effect Checklist used to monitor common medication side effects., 6 weeks |
Sponsor/Collaborators: Sponsor: University of Maryland, Baltimore | Collaborators: US Department of Veterans Affairs
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 13
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-08
Completion Date: 2011-12
Results First Posted: 2013-06-14
Last Update Posted: 2022-03-11
Locations: Baltimore VA Medical Center, Baltimore, Maryland, 21201, United States|Maryland Psychiatric Research Center, Baltimore, Maryland, 21228, United States
URL: https://clinicaltrials.gov/show/NCT01182727